Retinal Biologics Market to Reach $24.7 Billion, Globally, by 2032 at 5.1% CAGR: Allied Market Research Portland, OR, July 13, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Retinal Biologics Market By Drug Class (VEGF-A Antagonist and Others), By Indication, (Macular...

Retinal Biologics Market worth USD 34,891.44 Million by 2027, at 11.5% CAGR | Market Research Future (MRFR) Pune, India, June 10, 2021 (GLOBE NEWSWIRE) -- Retinal Biologics Market Overview: Market Research Future (MRFR) anticipates the Retinal Biologics Market to obtain a valuation of USD 34,891.44...

Retinal Biologics Market to hit US $18.3 billion by 2028 - Global Insights on Trends, Growth Drivers, Investment Plans, Expansion Analysis, COVID-18 Impact, Key Players and Future Opportunities: Adroit Market Research Dallas, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The global retinal biologics market is projected to grow at a CAGR of 6.5%. Increasing prevalence of retinal disorders such as macular degeneration,...

Global Retinal Biologics Market Will Reach to USD 28,015 Million By 2025: Zion Market Research New York, NY, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Retinal Biologics Market By Drug Class (TNF-a Inhibitor and VEGF-A Antagonist), By Indication...